Market Research Logo

Australia Vision Care Market Outlook to 2022

Australia Vision Care Market Outlook to 2022

Summary

GlobalData’s new report, Australia Vision Care Market Outlook to 2022, provides key market data on the Australia Vision Care market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segements - Contact Lenses, Spectacle Lenses, Contact Lens Cleaning and Disinfecting Solutions and Microkeratomes.

The report also provides company shares and distribution shares data for each of these market segements, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Vision Care market segements - Contact Lenses, Spectacle Lenses, Contact Lens Cleaning and Disinfecting Solutions and Microkeratomes.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segements. Data is provided from 2008 to 2015 and forecast to 2022.
  • 2015 company shares and distribution shares data for each of the market segements.
  • Global corporate-level profiles of key companies operating within the Australia Vision Care market.
  • Key players covered include Alcon, Inc., Essilor International, Bausch & Lomb Incorporated, Carl Zeiss AG and Others.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand capitalize.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Vision Care Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Vision Care Market, Australia
3.1 Vision Care Market, Australia, Revenue ($m), 2008-2015
3.2 Vision Care Market, Australia, Revenue ($m), 2015-2022
3.2.1 Contact Lens Cleaning and Disinfecting Solutions Market, Australia, Revenue ($m), by Segment, 2008-2015
3.2.2 Contact Lenses Market, Australia, Revenue ($m), by Segment, 2008-2015
3.2.3 Spectacle Lenses Market, Australia, Revenue ($m), by Segment, 2008-2015
3.2.4 Contact Lens Cleaning and Disinfecting Solutions Market, Australia, Revenue ($m), by Segment, 2015-2022
3.2.5 Contact Lenses Market, Australia, Revenue ($m), by Segment, 2015-2022
3.2.6 Spectacle Lenses Market, Australia, Revenue ($m), by Segment, 2015-2022
3.3 Vision Care Market, Australia, Volume (Units), 2008-2015
3.4 Vision Care Market, Australia, Volume (Units), 2015-2022
3.4.1 Contact Lens Cleaning and Disinfecting Solutions Market, Australia, Volume (Units), by Segment, 2008-2015
3.4.2 Contact Lenses Market, Australia, Volume (Units), by Segment, 2008-2015
3.4.3 Spectacle Lenses Market, Australia, Volume (Units), by Segment, 2008-2015
3.4.4 Contact Lens Cleaning and Disinfecting Solutions Market, Australia, Volume (Units), by Segment, 2015-2022
3.4.5 Contact Lenses Market, Australia, Volume (Units), by Segment, 2015-2022
3.4.6 Spectacle Lenses Market, Australia, Volume (Units), by Segment, 2015-2022
3.5 Vision Care Market, Australia, Average Price ($), 2008-2022
3.6 Vision Care Market, Australia, Distribution Share by Revenue ($m), 2014-2015
3.7 Vision Care Market, Australia, Company Share by Revenue ($m), 2015
4 Overview of Key Companies in Australia, Vision Care Market
4.1 Essilor International
4.1.1 Company Overview
4.2 Carl Zeiss AG
4.2.1 Company Overview
4.3 Bausch & Lomb Inc
4.3.1 Company Overview
4.4 Johnson & Johnson Vision Care Inc
4.4.1 Company Overview
4.5 CooperVision Inc
4.5.1 Company Overview
4.6 Hoya Corporation
4.6.1 Company Overview
4.7 Alcon, Inc.
4.7.1 Company Overview
5 Vision Care Market Pipeline Products
6 Recent Developments
6.1 Strategy And Business Planning
6.1.1 Feb 15, 2016: Chemence Medical Receives FDA Clearance for Exofin Tissue Adhesive
7 Appendix
7.1 Research Methodology
7.1.1 Coverage
7.1.2 Secondary Research
7.1.3 Primary Research
7.1.4 Company Share Analysis
7.1.5 Distribution Share Analysis
7.1.6 Benchmarking
7.2 GlobalData Consulting
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Ventricular Assist Devices - Pipeline Products by Stage of Development
Table 2: Ventricular Assist Devices - Pipeline Products by Segment
Table 3: Ventricular Assist Devices - Pipeline Products by Territory
Table 4: Ventricular Assist Devices - Pipeline Products by Regulatory Path
Table 5: Ventricular Assist Devices - Pipeline Products by Estimated Approval Date
Table 6: Ventricular Assist Devices - Ongoing Clinical Trials
Table 7: Ventricular Assist Devices Companies - Pipeline Products by Stage of Development
Table 8: Ventricular Assist Devices - Pipeline Products by Stage of Development
Table 9: Abiomed, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Impella 2.5 - Cardiogenic Shock - Product Status
Table 11: Impella 2.5 - Cardiogenic Shock - Product Description
Table 12: Impella 2.5 System - Product Status
Table 13: Impella 2.5 System - Product Description
Table 14: Impella 5.0 - Cardiogenic Shock - Product Status
Table 15: Impella 5.0 - Cardiogenic Shock - Product Description
Table 16: Impella 5.5 - Product Status
Table 17: Impella 5.5 - Product Description
Table 18: Impella BTR - Product Status
Table 19: Impella BTR - Product Description
Table 20: Impella CP - Product Status
Table 21: Impella CP - Product Description
Table 22: Impella CP - Cardiogenic Shock - Product Status
Table 23: Impella CP - Cardiogenic Shock - Product Description
Table 24: Impella ECP - Product Status
Table 25: Impella ECP - Product Description
Table 26: Impella RP - Product Status
Table 27: Impella RP - Product Description
Table 28: Next Generation Impella CP - STEMI - Product Status
Table 29: Next Generation Impella CP - STEMI - Product Description
Table 30: Abiomed, Inc. - Ongoing Clinical Trials Overview
Table 31: Impella RP - The Use of Impella RP Support System in Patients With Right Heart Failure: A Clinical and Probable Benefit Study
Table 32: Impella CP - Effects of Advanced Mechanical Circulatory Support in Patients With ST Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock. The Danish Cardiogenic Shock Trial
Table 33: Next Generation Impella CP - STEMI - Door to Unloading (DTU) with Impella CP System in Acute Myocardial Infarction to Reduce Infarct Size
Table 34: Biophan Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Myotech Circulatory Support System - Product Status
Table 36: Myotech Circulatory Support System - Product Description
Table 37: BioVentrix Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 38: Next Generation Revivent-TC System - Product Status
Table 39: Next Generation Revivent-TC System - Product Description
Table 40: PliCath HF - Product Status
Table 41: PliCath HF - Product Description
Table 42: BioVentrix Inc - Ongoing Clinical Trials Overview
Table 43: PliCath HF - Phase II Study of the BioVentrix PliCath HF System for the Treatment of Ischemic Cardiomyopathy
Table 44: Braile Biomedica Ltda Pipeline Products & Ongoing Clinical Trials Overview
Table 45: Blood Pump - Product Status
Table 46: Blood Pump - Product Description
Table 47: Calon Cardio-Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 48: BridgeVAD - Product Status
Table 49: BridgeVAD - Product Description
Table 50: Calon MiniVAD - Product Status
Table 51: Calon MiniVAD - Product Description
Table 52: CathVAD - Product Status
Table 53: CathVAD - Product Description
Table 54: CardiacAssist Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 55: Pediatric pVAD - Product Status
Table 56: Pediatric pVAD - Product Description
Table 57: CARDIAnove Pipeline Products & Ongoing Clinical Trials Overview
Table 58: CARDIAnove Pump - Product Status
Table 59: CARDIAnove Pump - Product Description
Table 60: Cardio Vox, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 61: Transcatheter Ventricular Assist Device - Product Status
Table 62: Transcatheter Ventricular Assist Device - Product Description
Table 63: CardioKinetix Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 64: Parachute Ventricular Partitioning Device - Product Status
Table 65: Parachute Ventricular Partitioning Device - Product Description
Table 66: CardioKinetix Inc - Ongoing Clinical Trials Overview
Table 67: Parachute Ventricular Partitioning Device - A Dual-Arm, Open-Label, Multi-Center Registry Designed To Evaluate The Parachute Implant in Ischemic Heart Failure Patients
Table 68: Parachute Ventricular Partitioning Device - Percutaneous Ventricular Restoration in Chronic Heart Failure Due to Ischemic Heart Disease
Table 69: Parachute Ventricular Partitioning Device - Percutaneous Ventricular Restoration in Chronic Heart Failure Due to Ischemic Heart Disease. A German Trial to Evaluate the Improvement in Quality of Life and Cardiac Output Following Implanting of the Parachute Implant System : PARACHUTE V
Table 70: CardioPlus, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 71: CardioPlus - Product Status
Table 72: CardioPlus - Product Description
Table 73: Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview
Table 74: tVAD - Heart Failure - Product Status
Table 75: tVAD - Heart Failure - Product Description
Table 76: Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview
Table 77: PediPump - Product Status
Table 78: PediPump - Product Description
Table 79: Cleveland Heart Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 80: SmartHeart LVAD - Product Status
Table 81: SmartHeart LVAD - Product Description
Table 82: CorAssist Cardiovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 83: CORolla - Product Status
Table 84: CORolla - Product Description
Table 85: ImCardia - Product Status
Table 86: ImCardia - Product Description
Table 87: CorAssist Cardiovascular Ltd - Ongoing Clinical Trials Overview
Table 88: CORolla - CORolla TAA for Heart Failure and Preserved Ejection Fraction and Diastolic Dysfunction
Table 89: CORolla - CORolla TAA for Heart Failure with Preserved Ejection Fraction (HFpEF) and Diastolic Dysfunction (DD) Safety and Feasibility
Table 90: Corinnova Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 91: CardiacSTAR - Bridge To Decision - Product Status
Table 92: CardiacSTAR - Bridge To Decision - Product Description
Table 93: CardiacSTAR - Bridge To Recovery - Product Status
Table 94: CardiacSTAR - Bridge To Recovery - Product Description
Table 95: CardiacSTAR - Bridge To Transplant - Product Status
Table 96: CardiacSTAR - Bridge To Transplant - Product Description
Table 97: CardiacSTAR - Destination Therapy - Product Status
Table 98: CardiacSTAR - Destination Therapy - Product Description
Table 99: CardiacSTAR - Heart Rehabilitation - Product Status
Table 100: CardiacSTAR - Heart Rehabilitation - Product Description
Table 101: CorWave Pipeline Products & Ongoing Clinical Trials Overview
Table 102: Left Ventricular Assist Device - Product Status
Table 103: Left Ventricular Assist Device - Product Description
Table 104: Drexel University Pipeline Products & Ongoing Clinical Trials Overview
Table 105: Intravascular Blood Pump - Product Status
Table 106: Intravascular Blood Pump - Product Description
Table 107: DUALIS MedTech GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 108: CAREFLOW Pump - Product Status
Table 109: CAREFLOW Pump - Product Description
Table 110: Duke University Pipeline Products & Ongoing Clinical Trials Overview
Table 111: Para-Aortic Blood Pump - Product Status
Table 112: Para-Aortic Blood Pump - Product Description
Table 113: Ension, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 114: CardioFlowPQ - Product Status
Table 115: CardioFlowPQ - Product Description
Table 116: Evaheart Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 117: EVAHEART Left Ventricular Assist System - Product Status
Table 118: EVAHEART Left Ventricular Assist System - Product Description
Table 119: Everheart Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 120: Fully Implantable Left Ventricular Assist Device - Product Status
Table 121: Fully Implantable Left Ventricular Assist Device - Product Description
Table 122: FineHeart Pipeline Products & Ongoing Clinical Trials Overview
Table 123: ICOMS - Product Status
Table 124: ICOMS - Product Description
Table 125: Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Pipeline Products & Ongoing Clinical Trials Overview
Table 126: Ventricular Assist Device - Product Status
Table 127: Ventricular Assist Device - Product Description
Table 128: Gold Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 129: Magnevad III - Product Status
Table 130: Magnevad III - Product Description
Table 131: HeartWare International Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 132: BiVAD - Product Status
Table 133: BiVAD - Product Description
Table 134: Fully Implantable VAD System - Product Status
Table 135: Fully Implantable VAD System - Product Description
Table 136: HeartWare IV-VAD - Product Status
Table 137: HeartWare IV-VAD - Product Description
Table 138: HeartWare Ventricular Assist Device - Bridge-To-Transplant - Product Status
Table 139: HeartWare Ventricular Assist Device - Bridge-To-Transplant - Product Description
Table 140: HeartWare Ventricular Assist Device - Destination Therapy - Product Status
Table 141: HeartWare Ventricular Assist Device - Destination Therapy - Product Description
Table 142: Levacor Rotary VAD - Product Status
Table 143: Levacor Rotary VAD - Product Description
Table 144: Longhorn - Product Status
Table 145: Longhorn - Product Description
Table 146: MiFlow VAD - Product Status
Table 147: MiFlow VAD - Product Description
Table 148: Miniaturized Ventricular Assist Device (MVAD) Pump - Product Status
Table 149: Miniaturized Ventricular Assist Device (MVAD) Pump - Product Description
Table 150: VCAN Trans-Mitral - Product Status
Table 151: VCAN Trans-Mitral - Product Description
Table 152: HeartWare International Inc - Ongoing Clinical Trials Overview
1.2 List of Figures
Figure 1: Vision Care Market, Australia, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 2: Vision Care Market, Australia, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 3: Contact Lens Cleaning and Disinfecting Solutions Market, Australia, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 4: Contact Lenses Market, Australia, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 5: Spectacle Lenses Market, Australia, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 6: Contact Lens Cleaning and Disinfecting Solutions Market, Australia, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 7: Contact Lenses Market, Australia, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 8: Spectacle Lenses Market, Australia, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 9: Vision Care Market, Australia, Volume (Units), Historic, 2008-2015
Figure 10: Vision Care Market, Australia, Volume (Units), Forecast, 2015-2022
Figure 11: Contact Lens Cleaning and Disinfecting Solutions Market, Australia, Volume (Units), Historic, 2008-2015
Figure 12: Contact Lenses Market, Australia, Volume (Units), Historic, 2008-2015
Figure 13: Spectacle Lenses Market, Australia, Volume (Units), Historic, 2008-2015
Figure 14: Contact Lens Cleaning and Disinfecting Solutions Market, Australia, Volume (Units), Forecast, 2015-2022
Figure 15: Contact Lenses Market, Australia, Volume (Units), Forecast, 2015-2022
Figure 16: Spectacle Lenses Market, Australia, Volume (Units), Forecast, 2015-2022
Figure 17: Vision Care Market, Australia, Company Share (%) 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report